|
|
|
Corporate Profile: Agennix
| Summary: |
| Agennix,
a Houston-based biopharmaceutical company, is the
world leader in the development of recombinant human
lactoferrin (rhLF), a natural immuno-stimulatory
and anti-inflammatory protein. Agennix is the first
and only company to manufacture commercial quantities
of human lactoferrin and holds global patents on
its technology, with 73 issued patents and more
than 50 patents pending. |
| Address: |
8 Greenway Plaza
Suite 910
Houston, TX 77054 |
| Phone
#'s: |
| Main |
(713) 796-1091 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s: |
| Main |
(713) 552-0795 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| not
known |
| Number
of employees: |
| not
known |
| Issued United States patents: |
| Issued U.S.
patents 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
